ARK Invest increased its holdings of Meta and Pacific Biosciences yesterday, while reducing its holdings of Teradyne, Palantir, and others According to TechFlow, on October 23rd, according to ARK Invest, Cathy Wood's ARK fund adjusted its holdings in multiple stocks. In terms of buying: Meta Platforms (META): ARKK bought 28069 shares, accounting for 0.2901% of the fund proportion. ARKW bought 7018 shares, accounting for 0.2442%. ARKF bought 3023 shares, accounting for 0.2455%. Pacific Biosciences (PACB): ARKK bought 266184 shares, accounting for 0.0089%. ARKG bought 88512 shares, accounting for 0.0094%. ARKG also purchased 99254 shares of Scribe Therapeutics (SCTX), accounting for 0.0877%. Simultaneously purchased 35377 shares of Freenome (FRNM), accounting for 0.0229%, and 6604 shares of Iambic Therapeutics (IAM), accounting for 0.0051%. ARKW bought 5397 shares of Shopify (SHOP), accounting for 0.0482%. In terms of sales: ARKK sold 57444 shares of Teradyne (TER), accounting for 0.2836%. ARKW sold 33793 shares of Roblox (RBLX), accounting for 0.0962%. Simultaneously sold 23020 shares of Block (XYZ), accounting for 0.0971%. ARKF sold 7936 shares of Palantir (PLTR), accounting for 0.1940%.